Recombinant and haemarthrosis Patient Reports February 10, 2010

Recombinant Side Effects Report #5069865-7
Recombinant side effect was reported by a Physician from FRANCE on July 10, 2006. Male patient, 13 years of age, was diagnosed with factor viii deficiency and was treated with Recombinant. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haemarthrosis. Recombinant dosage: unknown. During the same period patient was treated with HEXATRIONE. Patient was hospitalized. Patient recovered.